Integer Holdings Corporation
Financials
Valuation Metrics
Integer Holdings Corporation's Market Cap is $4.23B. At end of 2025 it was $2.73B. Ranked #1532 of 3,111 in US market (top 49%), #1000 of 1,666 on NYSE (top 60%), #88 of 206 in Health Care Equipment & Services (top 43%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.23B | US#1,532/3,111 Sec#88/206 |
| Revenue | $1.85B | US#1,532/3,111 Sec#96/206 |
| Net Income | $142M | US#1,439/3,111 Sec#68/206 |
| Total Assets | $3.41B | US#1,716/3,111 Sec#79/206 |
| Net Assets | $1.70B | US#1,382/3,111 Sec#70/206 |
| Employees | 11,000 | US#563/3,111 Sec#52/206 |
| Value | ||
| P/E | 29.80x | US#1,435/3,111 Sec#50/206 |
| P/B | 2.49x | US#1,449/3,111 Sec#80/206 |
| P/S | 2.28x | US#1,389/3,111 Sec#102/206 |
| EV/EBITDA | 16.84x | US#1,639/3,111 Sec#69/206 |
| FCF Yield | 2.36% | US#1,876/3,111 Sec#117/206 |
| Profitability | ||
| ROE | 8.36% | US#1,554/3,111 Sec#75/206 |
| ROA | 4.16% | US#1,162/3,111 Sec#71/206 |
| Op. Margin | 10.41% | US#1,604/3,111 Sec#75/206 |
| Revenue Growth | 0.78% | US#2,174/3,111 Sec#164/206 |
| Earnings Growth | -14.29% | US#1,588/3,111 Sec#76/206 |
| Financial Health | ||
| Debt Ratio | 101.06% | US#1,109/3,111 Sec#107/206 |
| Total Debt | $1.38B | US#1,337/3,111 Sec#69/206 |
| FCF | $100M | US#1,672/3,111 Sec#102/206 |
| Cash | $8M | US#2,977/3,111 Sec#205/206 |
| Current Ratio | 3.75x | US#613/3,111 Sec#61/206 |
| Net Debt/EBITDA | 4.13x | US#1,884/3,111 Sec#120/206 |
| Performance | ||
| 1Y Return | 16.83% | US#1,670/3,111 Sec#111/206 |
| 1M Return | 30.81% | US#45/3,111 Sec#9/206 |
| From 52W High | -0.87% | US#127/3,111 Sec#9/206 |
| 1Y MDD | -48.51% | US#2,349/3,111 Sec#141/206 |
| Trading | ||
| Volume | 12,050,862 shares | US#744/3,111 Sec#43/206 |
| Trading Value | $1.50B | US#378/3,111 Sec#25/206 |
| Per Share | ||
| EPS | $2.95 | US#1,000/3,111 Sec#56/206 |
| BPS | $50.10 | US#429/3,111 Sec#30/206 |
Company Info
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.